Verona Pharma Reports Positive Top-Line Data from Phase 2b Clinical Trial of RPL554 for Maintenance Treatment of COPD
BioTech Gate,
Primary endpoint met; RPL554 produced clinically and statistically significant improvements in lung function at all dose levels…